AAC -- Table of Contents (September 1 1997, 41 [9])

Receive this page by e-mail each issue: [Sign up for eTOCs]

Contents: September 1997, Volume 41, Issue 9

Articles

Other Issues

FREE CONTENT FROM ASM

AUTHOR-SPONSORED OPEN ACCESS

Table of Contents

To see an article, click its [Full Text], [Abstract] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:

Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitro
DC McFadden, F Seeber, and JC Boothroyd
Antimicrob. Agents Chemother. September 1997 41: 1849-1853;
[Abstract] [PDF] [Reprints and Permissions]

Enterococcal transposon Tn5384: evolution of a composite transposon through cointegration of enterococcal and staphylococcal plasmids
ME Bonafede, LL Carias, and LB Rice
Antimicrob. Agents Chemother. September 1997 41: 1854-1858;
[Abstract] [PDF] [Reprints and Permissions]

Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl- isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology
JA Silverman, ML Hayes, BJ Luft, and KA Joiner
Antimicrob. Agents Chemother. September 1997 41: 1859-1866;
[Abstract] [PDF] [Reprints and Permissions]

Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin
MA Visalli, MR Jacobs, and PC Appelbaum
Antimicrob. Agents Chemother. September 1997 41: 1867-1870;
[Abstract] [PDF] [Reprints and Permissions]

Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma
KM Wasan, M Ramaswamy, SM Cassidy, M Kazemi, FW Strobel, and RL Thies
Antimicrob. Agents Chemother. September 1997 41: 1871-1875;
[Abstract] [PDF] [Reprints and Permissions]

Influence of electric fields and pH on biofilm structure as related to the bioelectric effect
P Stoodley, D deBeer, and HM Lappin-Scott
Antimicrob. Agents Chemother. September 1997 41: 1876-1879;
[Abstract] [PDF] [Reprints and Permissions]

Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues
M Pettoello-Mantovani, TR Kollmann, C Raker, A Kim, S Yurasov, R Tudor, H Wiltshire, and H Goldstein
Antimicrob. Agents Chemother. September 1997 41: 1880-1887;
[Abstract] [PDF] [Reprints and Permissions]

Cerebrospinal fluid bactericidal activity against cephalosporin- resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime
IR Friedland and KP Klugman
Antimicrob. Agents Chemother. September 1997 41: 1888-1891;
[Abstract] [PDF] [Reprints and Permissions]

Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients
MT Borin, SR Cox, BD Herman, BJ Carel, RD Anderson, and WW Freimuth
Antimicrob. Agents Chemother. September 1997 41: 1892-1897;
[Abstract] [PDF] [Reprints and Permissions]

In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced
D Sereno and JL Lemesre
Antimicrob. Agents Chemother. September 1997 41: 1898-1903;
[Abstract] [PDF] [Reprints and Permissions]

Streptogramin B biosynthesis in Streptomyces pristinaespiralis and Streptomyces virginiae: molecular characterization of the last structural peptide synthetase gene
V de Crecy-Lagard, W Saurin, D Thibaut, P Gil, L Naudin, J Crouzet, and V Blanc
Antimicrob. Agents Chemother. September 1997 41: 1904-1909;
[Abstract] [PDF] [Reprints and Permissions]

Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model
JD Knudsen, K Fuursted, F Espersen, and N Frimodt-Moller
Antimicrob. Agents Chemother. September 1997 41: 1910-1915;
[Abstract] [PDF] [Reprints and Permissions]

Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis
GS Perdikaris, A Pefanis, H Giamarellou, A Nikolopoulos, EP Margaris, I Donta, A Tsitsika, and P Karayiannakos
Antimicrob. Agents Chemother. September 1997 41: 1916-1921;
[Abstract] [PDF] [Reprints and Permissions]

Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha- difluoromethylornithine
M Iten, H Mett, A Evans, JC Enyaru, R Brun, and R Kaminsky
Antimicrob. Agents Chemother. September 1997 41: 1922-1925;
[Abstract] [PDF] [Reprints and Permissions]

Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies
PD Lister, A Pong, SA Chartrand, and CC Sanders
Antimicrob. Agents Chemother. September 1997 41: 1926-1932;
[Abstract] [PDF] [Reprints and Permissions]

Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice
H Thadepalli, SK Chuah, U Reddy, N Hanna, R Clark, RJ Polzer, and S Gollapudi
Antimicrob. Agents Chemother. September 1997 41: 1933-1936;
[Abstract] [PDF] [Reprints and Permissions]

Treatment of murine Candida krusei or Candida glabrata infection with L- 743,872
JR Graybill, R Bocanegra, M Luther, A Fothergill, and MJ Rinaldi
Antimicrob. Agents Chemother. September 1997 41: 1937-1939;
[Abstract] [PDF] [Reprints and Permissions]

Construction and characterization of an OHIO-1 beta-lactamase bearing Met69Ile and Gly238Ser mutations
RA Bonomo, JR Knox, SD Rudin, and DM Shlaes
Antimicrob. Agents Chemother. September 1997 41: 1940-1943;
[Abstract] [PDF] [Reprints and Permissions]

Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis
TJ Walsh, P Whitcomb, S Piscitelli, WD Figg, S Hill, SJ Chanock, P Jarosinski, R Gupta, and PA Pizzo
Antimicrob. Agents Chemother. September 1997 41: 1944-1948;
[Abstract] [PDF] [Reprints and Permissions]

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104
EJ Eisenberg, A Bidgood, and KC Cundy
Antimicrob. Agents Chemother. September 1997 41: 1949-1952;
[Abstract] [PDF] [Reprints and Permissions]

High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks
B Ji, P Jamet, S Sow, EG Perani, I Traore, and JH Grosset
Antimicrob. Agents Chemother. September 1997 41: 1953-1956;
[Abstract] [PDF] [Reprints and Permissions]

Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans
TV Krishnarao and JN Galgiani
Antimicrob. Agents Chemother. September 1997 41: 1957-1960;
[Abstract] [PDF] [Reprints and Permissions]

Effect of foscarnet cream on experimental UV radiation-induced herpes labialis
DI Bernstein, CJ Schleupner, TG Evans, DA Blumberg, Y Bryson, K Grafford, P Broberg, S Martin-Munley, and SL Spruance
Antimicrob. Agents Chemother. September 1997 41: 1961-1964;
[Abstract] [PDF] [Reprints and Permissions]

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
TM File, Jr, J Segreti, L Dunbar, R Player, R Kohler, RR Williams, C Kojak, and A Rubin
Antimicrob. Agents Chemother. September 1997 41: 1965-1972;
[Abstract] [PDF] [Reprints and Permissions]

Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae
V Zeller, C Janoir, MD Kitzis, L Gutmann, and NJ Moreau
Antimicrob. Agents Chemother. September 1997 41: 1973-1978;
[Abstract] [PDF] [Reprints and Permissions]

Amoxicillin treatment of experimental acute otitis media caused by Haemophilus influenzae with non-beta-lactamase-mediated resistance to beta-lactams: aspects of virulence and treatment
A Melhus, H Janson, E Westman, A Hermansson, A Forsgren, and K Prellner
Antimicrob. Agents Chemother. September 1997 41: 1979-1984;
[Abstract] [PDF] [Reprints and Permissions]

Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits
T Toyoguchi, S Takahashi, J Hosoya, Y Nakagawa, and H Watanabe
Antimicrob. Agents Chemother. September 1997 41: 1985-1990;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves
BA de Craene, P Deprez, E D'Haese, HJ Nelis, W Van den Bossche, and P De Leenheer
Antimicrob. Agents Chemother. September 1997 41: 1991-1995;
[Abstract] [PDF] [Reprints and Permissions]

Structure-absorption relationships of a series of 6-fluoroquinolones
E Escribano, AC Calpena, TM Garrigues, J Freixas, J Domenech, and J Moreno
Antimicrob. Agents Chemother. September 1997 41: 1996-2000;
[Abstract] [PDF] [Reprints and Permissions]

Rapid assessment of antibiotic effects on Escherichia coli by bis-(1,3- dibutylbarbituric acid) trimethine oxonol and flow cytometry
RI Jepras, FE Paul, SC Pearson, and MJ Wilkinson
Antimicrob. Agents Chemother. September 1997 41: 2001-2005;
[Abstract] [PDF] [Reprints and Permissions]

Synergistic anticryptosporidial potential of the combination alpha-1- antitrypsin and paromomycin
JR Forney, S Yang, and MC Healey
Antimicrob. Agents Chemother. September 1997 41: 2006-2008;
[Abstract] [PDF] [Reprints and Permissions]

Influence of OprM expression on multiple antibiotic resistance in Pseudomonas aeruginosa
KK Wong, K Poole, N Gotoh, and RE Hancock
Antimicrob. Agents Chemother. September 1997 41: 2009-2012;
[Abstract] [PDF] [Reprints and Permissions]

Penicillin-binding proteins and induction of AmpC beta-lactamase
CC Sanders, PA Bradford, AF Ehrhardt, K Bush, KD Young, TA Henderson, and WE Sanders, Jr
Antimicrob. Agents Chemother. September 1997 41: 2013-2015;
[Abstract] [PDF] [Reprints and Permissions]

VanD-type glycopeptide-resistant Enterococcus faecium BM4339
B Perichon, P Reynolds, and P Courvalin
Antimicrob. Agents Chemother. September 1997 41: 2016-2018;
[Abstract] [PDF] [Reprints and Permissions]

Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004)
LM Ednie, MR Jacobs, and PC Appelbaum
Antimicrob. Agents Chemother. September 1997 41: 2019-2022;
[Abstract] [PDF] [Reprints and Permissions]

Association of mutations in grlA and gyrA topoisomerase genes with resistance to ciprofloxacin in epidemic and sporadic isolates of methicillin-resistant Staphylococcus aureus
A Deplano, A Zekhnini, N Allali, M Couturier, and MJ Struelens
Antimicrob. Agents Chemother. September 1997 41: 2023-2025;
[Abstract] [PDF] [Reprints and Permissions]

Efficacy of nikkomycin Z against experimental pulmonary blastomycosis
KV Clemons and DA Stevens
Antimicrob. Agents Chemother. September 1997 41: 2026-2028;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetic interaction between itraconazole and ceftriaxone in Yucatan miniature pigs
A Cavalier, D Leveque, JD Peter, J Salmon, H Elkhaili, Y Salmon, P Nobelis, J Geisert, H Monteil, and F Jehl
Antimicrob. Agents Chemother. September 1997 41: 2029-2032;
[Abstract] [PDF] [Reprints and Permissions]

In vitro activity of trovafloxacin against Chlamydia pneumoniae
PM Roblin, A Kutlin, and MR Hammerschlag
Antimicrob. Agents Chemother. September 1997 41: 2033-2034;
[Abstract] [PDF] [Reprints and Permissions]

Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages
N Mor and A Esfandiari
Antimicrob. Agents Chemother. September 1997 41: 2035-2036;
[Abstract] [PDF] [Reprints and Permissions]

Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones
PC Hannan, GD Windsor, A de Jong, N Schmeer, and M Stegemann
Antimicrob. Agents Chemother. September 1997 41: 2037-2040;
[Abstract] [PDF] [Reprints and Permissions]

A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins
A Bauernfeind, S Wagner, R Jungwirth, I Schneider, and D Meyer
Antimicrob. Agents Chemother. September 1997 41: 2041-2046;
[Abstract] [PDF] [Reprints and Permissions]

Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group
ME Falagas, L McDermott, and DR Snydman
Antimicrob. Agents Chemother. September 1997 41: 2047-2049;
[Abstract] [PDF] [Reprints and Permissions]

Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin
C Doit, J Barre, R Cohen, S Bonacorsi, A Bourrillon, and EH Bingen
Antimicrob. Agents Chemother. September 1997 41: 2050-2052;
[Abstract] [PDF] [Reprints and Permissions]

In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
M Manduru, LB Mihm, RL White, LV Friedrich, PA Flume, and JA Bosso
Antimicrob. Agents Chemother. September 1997 41: 2053-2056;
[Abstract] [PDF] [Reprints and Permissions]

Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis
CL Kelley, DA Rouse, and SL Morris
Antimicrob. Agents Chemother. September 1997 41: 2057-2058;
[Abstract] [PDF] [Reprints and Permissions]

Adaptive mutations produce resistance to ciprofloxacin
C Riesenfeld, M Everett, LJ Piddock, and BG Hall
Antimicrob. Agents Chemother. September 1997 41: 2059-2060;
[Abstract] [PDF] [Reprints and Permissions]

Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: effects of complexation with copper(II), gallium(III), and iron (III) on their antiproliferative activities
DR Richardson
Antimicrob. Agents Chemother. September 1997 41: 2061-2063;
[Abstract] [PDF] [Reprints and Permissions]

In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis
C Hennequin, N Benailly, C Silly, M Sorin, P Scheinmann, G Lenoir, JL Gaillard, and P Berche
Antimicrob. Agents Chemother. September 1997 41: 2064-2066;
[Abstract] [PDF] [Reprints and Permissions]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.